Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 30;12(4):836.
doi: 10.3390/antiox12040836.

Antioxidant Supplementation on Male Fertility-A Systematic Review

Affiliations
Review

Antioxidant Supplementation on Male Fertility-A Systematic Review

Fotios Dimitriadis et al. Antioxidants (Basel). .

Abstract

Our aim was to review the current literature regarding the effect of antioxidant supplementation (AS) on male fertility parameters, as AS is commonly used to treat male infertility due to the availability and affordability of antioxidants in many parts of the world.

Materials and methods: PubMed, Medline, and Cochrane electronic bibliographies were searched using the modified Preferred Reporting Items for Systemic Reviews and Meta-Analyses (PRISMA) guidelines to evaluate studies on the benefit of antioxidant therapy on infertile men. Results were analyzed regarding the following aspects: (a) ingredient and dose; (b) potential mechanism of action and rationale for use; and (c) effect on various reported outcomes.

Results: Thus, 29 studies found a substantial positive effect of AS on outcomes of assisted reproductive therapy (ART), WHO semen parameters, and live-birth rate. Carnitines, Vitamin E and C, N-acetyl cysteine, coenzyme Q10, selenium, zinc, folic acid, and lycopene were beneficial ingredients. Nevertheless, some studies did not show a substantial change in one or more factors.

Conclusion: AS seems to have a positive effect on male fertility. Environmental factors may play an increasing role in fertility. Further studies are needed to determine the optimal AS combination and the influence of environmental factors.

Keywords: antioxidant; male fertility; supplementation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flowchart of study selection.

References

    1. Brugh V.M., Lipshultz L.I. Male Factor Infertility Evaluation and Management. Med. Clin. N. Am. 2004;88:367–385. doi: 10.1016/S0025-7125(03)00150-0. - DOI - PubMed
    1. Irvine D.S. Epidemiology and Aetiology of Male Infertility. Hum. Reprod. 1998;13:33–44. doi: 10.1093/humrep/13.suppl_1.33. - DOI - PubMed
    1. Sharlip I.D., Jarow J.P., Belker A.M., Lipshultz L.I., Sigman M., Thomas A.J., Schlegel P.N., Howards S.S., Nehra A., Damewood M.D., et al. Best Practice Policies for Male Infertility. Fertil. Steril. 2002;77:873–882. doi: 10.1016/S0015-0282(02)03105-9. - DOI - PubMed
    1. Wong W.Y., Thomas C.M.G., Merkus J.M.W.M., Zielhuis G.A., Steegers-Theunissen R.P.M. Male Factor Subfertility: Possible Causes and the Impact of Nutritional Factors. Fertil. Steril. 2000;73:435–442. doi: 10.1016/S0015-0282(99)00551-8. - DOI - PubMed
    1. Dimitriadis F., Symeonidis E.N., Tsounapi P., Kaltsas A., Hatzichristodoulou G., Sokolakis I., Zachariou A., Takenaka A., Sofikitis N. Administration of Antioxidants in Infertile Male: When It May Have a Detrimental Effect? Curr. Pharm. Des. 2021;27:2796–2801. doi: 10.2174/1381612827666210204160248. - DOI - PubMed